[go: up one dir, main page]

AU2002345165A1 - The use of rhein and derivatives thereof in pain treatment - Google Patents

The use of rhein and derivatives thereof in pain treatment

Info

Publication number
AU2002345165A1
AU2002345165A1 AU2002345165A AU2002345165A AU2002345165A1 AU 2002345165 A1 AU2002345165 A1 AU 2002345165A1 AU 2002345165 A AU2002345165 A AU 2002345165A AU 2002345165 A AU2002345165 A AU 2002345165A AU 2002345165 A1 AU2002345165 A1 AU 2002345165A1
Authority
AU
Australia
Prior art keywords
rhein
derivatives
pain treatment
pain
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002345165A
Inventor
Robin Mark Bannister
Alan Rothaul
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sosei R&D Ltd
Original Assignee
Arakis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arakis Ltd filed Critical Arakis Ltd
Publication of AU2002345165A1 publication Critical patent/AU2002345165A1/en
Abandoned legal-status Critical Current

Links

AU2002345165A 2001-06-25 2002-06-24 The use of rhein and derivatives thereof in pain treatment Abandoned AU2002345165A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0115489.7 2001-06-25
GB0119173.3 2001-08-06

Publications (1)

Publication Number Publication Date
AU2002345165A1 true AU2002345165A1 (en) 2003-01-08

Family

ID=

Similar Documents

Publication Publication Date Title
AU2001293553A1 (en) Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment
AU2003291609A1 (en) Cb 1/cb 2 receptor ligands and their use in the treatment of pain
AU2001259758A1 (en) Interleukin-1 inhibitors in the treatment of diseases
AU2003243551A1 (en) Use of an anti-endotoxin drug in the prevention and treatment of disease
HUP0301121A3 (en) Topical pharmaceutical formulations and methods of treatment
AU2001283285A1 (en) Antimicrobial composition and methods of use in the treatment of disease
AU2003202075A1 (en) Modulator of the notch signalling pathway and use thereof in medical treatment
AU2002345255A1 (en) Composition comprising soy and use thereof in the prevention and/or treatment of various diseases
AU2002247208A1 (en) Selective pde3b inhibitors and use of the same in therapy
AU2001270484A1 (en) Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations
AU2002252976A1 (en) Hydrazones and their therapeutic use
AU2002241661A1 (en) Multifunctional protease inhibitors and their use in treatment of disease
AU2003286285A1 (en) Use of fgf-18 in the diagnosis and treatment of memory disorders
AU2003238242A1 (en) Use of an anti-endotoxin drug in the prevention and treatment of disease
AU2002352566A1 (en) Use of corrinoids in the treatment of skin diseases
AU2003244455A1 (en) Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
GB0007217D0 (en) Materials and methods relating to the treatment of leukaemias
AU2002210763A1 (en) Use of 1-ebio in the treatment of bipolar disorders
AU2003270350A1 (en) Isoxazoles and their use in the treatment of ischemic diseases
AU2001296477A1 (en) Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
AU2002345165A1 (en) The use of rhein and derivatives thereof in pain treatment
AU2003240446A1 (en) Use of mob-5 in pain
AU6330300A (en) Use of interleukin-6 in treatment of obesity and/or obesity associated disorders
AU2003244437A1 (en) Quinoxalinones and their use especially in the treatment of cardiovascular diseases
AU2001254825A1 (en) Butenoic acids derivatives and their use in the treatment of rhinitis